Phase
Condition
Limb Spasticity
Treatment
calcium folinate
Clinical Study ID
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients meet the clinical diagnostic standard of hereditary spastic paraplegia (HSP);
Spastic paraplegia type 56 (SPG56) was diagnosed by CYP2U1 pathogenic mutation;
Patients are willing to participate in clinical trials and able to understand andcomply with the research program.
Exclusion
Exclusion Criteria:
Patients are allergic to the drugs involved in the study;
Other neurological diseases likely affecting the evaluation of study treatment;
Other medical conditions such as: heart disease, tumor, blood disease, liverdisease, kidney disease, etc. in the past 1 year;
Pregnancy or lactating women or subjects who are unable to use appropriatecontraception during the trial;
Participating in another study drug trial and used the investigational drug in thepast 30 days;
Subjects have poor compliance or other factors that are not suitable forparticipating in the clinical trial.
Study Design
Connect with a study center
Shanghai 6th People's Hospita
Shanghai, Shanghai
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.